{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T05:20:51Z","timestamp":1735276851525,"version":"3.32.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Insulin pens are the mainstay of insulin delivery in the pediatric population, especially among patients unable to use an insulin pump. Safety pen needle (SPN) devices have been embraced by both nurses and patients because they limit the risks of needlestick injury and exposure to blood-borne pathogens. With the commonly used traditional passive SPN device, however, it can be difficult to observe that the dose has been accurately or fully administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study was to determine nurses' perceptions about the feasibility of using an active SPN device (specifically the Unifine SafeControl insulin pen needle), compared with the currently used passive SPN device, in pediatric patients ages 21 years or younger who require subcutaneous insulin injections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This feasibility study was conducted on a pediatric inpatient unit at 1 pediatric hospital in the southeastern United States. A total of 49 RNs completed both a pre\u2013device change survey regarding the currently used passive SPN device and a post\u2013device change survey regarding the active SPN device. The RNs also completed daily evaluations assessing the ease of teaching patients and their caregivers how to use the active SPN device. Participation consent was also obtained for 132 pediatric patients with diabetes who were admitted to the unit.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The majority of the RNs (87.8%) reported overall satisfaction with the active SPN device, compared to about half (52.7%) who reported overall satisfaction with the passive SPN device. Almost all the RNs (98.6%) reported that the active SPN device was easy or very easy to use. Nearly all the nurses (93.9%) reported feeling completely or very confident that the active SPN device allowed them to deliver the full intended dose; and nearly all reported that it was easy or very easy to teach patients (98.2%) and their caregivers (96.4%) how to use the active device.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>As frontline workers in patient care, nurses can lead the innovation and development of new treatment approaches, protocols, and equipment. This nurse-led study explored the nurses' perceptions about the feasibility of a new active SPN device versus the passive SPN device in terms of safety, ease of use, ease of and confidence in dose administration, and ease of teaching device use to pediatric patients and their caregivers. The RNs' clear preference for the active over the passive SPN device suggests that the newer, active devices warrant more widespread use in hospital settings, with further research also recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ajn.0000000000000001","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T13:00:31Z","timestamp":1734094831000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Original Research: Exploring the Use of Passive vs. Active Insulin Safety Pen Needle Devices in a Pediatric Population: A Feasibility Study"],"prefix":"10.1097","volume":"125","author":[{"given":"Brenna","family":"Frankish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Amplo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonya","family":"Miller-Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane Fujimoto","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Calamaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"issue":"6","key":"R1-20241226","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s13300-020-00831-z","article-title":"Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"key":"R2-20241226","doi-asserted-by":"crossref","first-page":"827484","DOI":"10.3389\/fendo.2022.827484","article-title":"The review of insulin pens\u2014past, present, and look to the future","volume":"13","author":"Masierek","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R4-20241226","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40842-015-0015-3","article-title":"Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis","volume":"1","author":"Veronesi","year":"2015","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"R5-20241226","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/1573399811666150806150210","article-title":"A prospective study for introducing insulin pens and safety needles in a hospital setting. The SANITHY study","volume":"12","author":"Bossi","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"R6-20241226","article-title":"Needlestick [internet]","author":"King","year":"2023","journal-title":"StatPearls"},{"issue":"1","key":"R7-20241226","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12199-018-0734-z","article-title":"Prevalence of needlestick and sharps injuries in the healthcare workers of Iranian hospitals: an updated meta-analysis","volume":"23","author":"Ghanei Gheshlagh","year":"2018","journal-title":"Environ Health Prev Med"},{"issue":"1","key":"R10-20241226","first-page":"90","article-title":"Barriers to the adoption of safety-engineered needles following a regulatory standard: lessons learned from three acute care hospitals","volume":"11","author":"Chambers","year":"2015","journal-title":"Healthc Policy"},{"issue":"2","key":"R11-20241226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s13300-017-0242-y","article-title":"Errors in the administration technique of insulin pen devices: a result of insufficient education","volume":"8","author":"Truong","year":"2017","journal-title":"Diabetes Ther"},{"issue":"1","key":"R12-20241226","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcjd.2016.07.001","article-title":"Examining factors that impact inpatient management of diabetes and the role of insulin pen devices","volume":"41","author":"Smallwood","year":"2017","journal-title":"Can J Diabetes"},{"issue":"7","key":"R14-20241226","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11136-018-1847-y","article-title":"The importance of content and face validity in instrument development: lessons learnt from service users when developing the Recovering Quality of Life measure (ReQoL)","volume":"27","author":"Connell","year":"2018","journal-title":"Qual Life Res"},{"key":"R15-20241226","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"R16-20241226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"Suppl 1","key":"R17-20241226","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.2337\/dc23-S014","article-title":"14. Children and adolescents: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"R18-20241226","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1089\/dia.2014.0072","article-title":"Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting","volume":"16","author":"Shogbon","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"R19-20241226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.healthpol.2010.02.006","article-title":"Managing diabetes-related costs and quality of life issues: value of insulin analogs and pens for inpatient use","volume":"96","author":"Cornell","year":"2010","journal-title":"Health Policy"},{"issue":"14","key":"R20-20241226","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2146\/ajhp120728","article-title":"Biological contamination of insulin pens in a hospital setting","volume":"70","author":"Herdman","year":"2013","journal-title":"Am J Health Syst Pharm"},{"issue":"14","key":"R21-20241226","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2146\/ajhp100535","article-title":"Impact of an interchange program to support use of insulin pens","volume":"68","author":"Ward","year":"2011","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"R22-20241226","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.NURSE.0000545015.98790.27","article-title":"Keeping up-to-date with diabetes care and education","volume":"48","author":"Funnell","year":"2018","journal-title":"Nursing"},{"key":"R23-20241226","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach's alpha","volume":"2","author":"Tavakol","year":"2011","journal-title":"Int J Med Educ"},{"author":"Shaw","key":"R24-20241226","article-title":"Supporting a culture of innovation and entrepreneurship (I and E) in nursing"}],"container-title":["AJN, American Journal of Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AJN.0000000000000001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T14:25:40Z","timestamp":1735223140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AJN.0000000000000001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ajn.0000000000000001","relation":{},"ISSN":["0002-936X","1538-7488"],"issn-type":[{"type":"print","value":"0002-936X"},{"type":"electronic","value":"1538-7488"}],"subject":[],"published":{"date-parts":[[2024,12,26]]}}}